@FierceMedDev: ICYMI: OrbiMed kicks off $735M VC fund with device and Dx companies in mind. Story | Follow @FierceMedDev
@MarkHFierce: The U.K. is banning the use of all-metal hips at NHS Hospitals. More | Follow @MarkHFierce
@MichaelGFierce: ICYMI: IBM uses hydrogel to prolong delivery of Roche's Herceptin. More from FierceDrugDelivery | Follow @MichaelGFierce
> Samsung has begun the U.S. rollout of its first digital radiology system, which won 510(k) clearance earlier this year. Item
> The FDA granted FzioMed's petition for an independent review of its premarket application for a gel used during lumbar spine surgery, a product that remains unapproved in the U.S. after 12 years of trying. Item
> Coloplast, a Danish medical device company, reported substantial growth in profit during its fiscal 2013 fourth quarter and year. Story
> A Minneapolis suburb has approved $2 million in subsidies to lure Olympus Surgical Technologies America from a competing suburb and help it expand. Story (sub. req.)
> Advanced Medical Isotope in Washington said it has applied for 510(k) clearance for a new brachytherapy cancer product. Item
> A new article explains why few medical devices are made with young children in mind. Story
Biotech News
@FierceBiotech: Roche heralds its return to the antibiotics field with $560M Polyphor deal. More | Follow @FierceBiotech
@JohnCFierce: ICYMI over the weekend: Merck's next-gen HPV vaccine looks good in PhIII, but sales may disappoint. Story | Follow @JohnCFierce
@DamianFierce: Oral testosterone developer Lipocine swings for $11.5M in S-1. More | Follow @DamianFierce
@EmilyMFierce: ICYMI: Key HIV protein structure revealed, paving way for new HIV/AIDS vaccine efforts. Story | Follow @EmilyMFierce
> Therapeutic vaccine upstart Hookipa snags $27M round to fund PhI move. News
> Merck's 'breakthrough' hep C combo plays catch-up with promising PhII results. More
> Bristol-Myers scores first marketing application for all-oral hep C combo. Story
Pharma News
@FiercePharma: HHS gives pharma the all-clear on co-pay assistance for Obamacare patients. Article | Follow @FiercePharma
@EricPFierce: Merck layoffs roll through to West Point, Pa plant with 500 jobs slated to go over X-mas holidays. News | Follow @EricPFierce
@CarlyHFierce: ICYMI: FDA helps generic drugmakers get copies of Glaxo's Advair to market. More | Follow @CarlyHFierce
> Reuters: GlaxoSmithKline likely to escape China charges, but execs probably won't. Story
> Ex-Lilly contract sales rep sues, claiming unpaid bonuses. News
CRO News
> Venn grabs German CRO, expands Euro footprint. Item
> Charles River bucks trend with spike in preclinical sales. Story
> Covance ups expectations thanks to booming lab biz. News
> Quintiles hikes income outlook as contracts pour in. More
> InVentiv grabs Catalina Health with eye on patient adherence. Report
> Parexel's stock plunges despite spikes in revenue, profit. Article
Biotech IT News
> NuMedii taps Thomson Reuters for data to power digital discovery model. More
> GoBalto rolls out version 2.0 of Tracker software. Item
> Rhenovia creates simulation of epilepsy biology. Story
> Rare disease dictionary gives bioinformatics databases a shared language. Article
> FDA working on drug shortages smartphone app. News
> Illumina to buy bioinformatics business NextBio. Report